There is one RCT on dexamethasone which shows improved patient survival - the RECOVERY study was terminated early, data has been published. The trial was terminated early for ethical reasons: Patient improvement - start here
https://www.recoverytrial.net/
Dexamethasone is now in use, usually on a hospital by hispital basis which results in a crazy crazy quilt.
The CDC will have to suggest it officially before some entities will consider its use.
There are other ongoing RCT's so you can see what is being studied:
https://clinicaltrials.gov/ct2/search
Because of the unreliable nature of internet sources other than google scholar, use that search engine and you can search for clinical studies (largely observational, not RCT).
Example try 'covid-19 proning', 'covid-19 age class mortality'
There is no completely reliable mortality data US wide because of local regulations which result in some hard to understand results. In other words confounding (or confusing) reporting practices. The JHU site displays what is officially published by local entities. An example of 'hard to understand' is Texas. They do not report hospitalization rates and some other data, plus the number of deaths seems relatively low, IMO.
The dashboard boxes have switch bars so the main display will show various data as different colored round blobs - you can pick the level of administrative granularity - Admin0, Admin1, Admin2. This shows current death rates.
https://coronavirus.jhu.edu/ go into the dashboard
Use the analytics section and you can see relative death rate reductions in states over time. Or some increases, too. Decreasing mortality rates may also continue as the fraction of younger people under hospital care increases in in-patient populations.
Dexmethasone is a win, however.